posteditor

B Popular event features keynotes from HGTV co-founder Susan Packard & green industry leader Judith Guido LOUISVILLE, Ky., May 14, 2026 /PRNewswire/ — Equip Exposition, the award-winning international landscape, outdoor living, and equipment exposition trade show, announced today its 2026 programming…

B Maryland’s Venture Capital Entity Promotes Executives COLUMBIA, Md., May 14, 2026 /PRNewswire/ — TEDCO, Maryland’s economic engine for technology companies, formally announced the promotions of Tammi Thomas to president and Geyssel Gonzalez to chief financial & technology officer. These…

MEMPHIS, Tenn. — A man was shot and killed Wednesday by a DEA agent at a Burger King in Frayser while federal agents served a warrant for his arrest, according to the Tennessee Bureau of Investigation. The TBI said it…

B GLG and Bloomberg Terminal® clients can now access the premium research provider’s unblinded expert transcripts directly via Bloomberg’s new conversational AI interface NEW YORK, May 14, 2026 /PRNewswire/ — GLG, the world’s leading platform for trusted human expertise, announced that…

B DAYTON, Ohio , May 14, 2026 /PRNewswire/ — DPL LLC (f/k/a DPL Inc.) (“DPL”) today announced the termination of its previously announced solicitation of consents (the “Expired Solicitation”) from registered holders (the “Holders”) of its 4.35% Senior Notes due 2029…

B Strategic Investment Fuels FDA Regulatory Path and Global Commercialization; Company to Showcase Technology at AUA 2026 BOSTON and YOKNEAM, Israel, May 14, 2026 /PRNewswire/ — Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced…

B Strengthening Leadership in Facilitating Japan’s Nationwide School Club Reform and Expanding Its Role as a Sustainable Education Infrastructure Provider TOKYO, May 14, 2026 /PRNewswire/ — LEIFRAS Co., Ltd. (Nasdaq: LFS) (the “Company” or “Leifras”), a sports and social business…

B SCARSDALE, N.Y., May 14, 2026 /PRNewswire/ — Maipl Therapeutics today highlighted continued preclinical progress for MA-4604, its lead investigational therapy for endometriosis. MA-4604 is a novel oral non-hormonal prostaglandin F2α receptor (FP) antagonist being developed to address the significant unmet…

B INDIANAPOLIS, May 14, 2026 /PRNewswire/ — IPALCO Enterprises, Inc. (“IPALCO”) today announced the termination of its previously announced solicitations of consents (each, an “Expired Solicitation” and, collectively, the “Expired Solicitations”) from registered holders (the “Holders”) of its 4.25% Senior…

B Peer-reviewed manuscript highlights regulatory gaps, industry challenges, and opportunities to strengthen pharmacovigilance as digital health technology adoption accelerates PHILADELPHIA, May 14, 2026 /PRNewswire/ — TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the…